On June 30, 2015, ScripsAmerica, Inc. announced that Robert Schneiderman, resigned as Chief Executive Officer, President, Secretary and from all other positions he held with subsidiaries and affiliates, including but not limited to Main Avenue Pharmacy, Inc., P.I.M.D. International, LLC, Wholesale Rx, Inc., and DispenseDoc, Inc. Upon the acceptance of Mr. Schneiderman's resignation on June 30, 2015, Brian Ettinger, the Chairman of Board of Directors became interim Chief Executive Officer and Chairman of Board of Directors and Adam Brosius became interim President. Mr. Ettinger and Mr. Brosius will serve in the forgoing capacities until suitable replacements are located. Brian Ettinger has served as a Director and Chairman of its Board of Directors since April 1, 2011.

Adam Brosius has served as consultant and Director of Business Development since May of 2012. Mr. Brosius negotiated several contracts and business arrangements with pharmaceutical partners.